Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours

被引:0
|
作者
Chih-Chieh Yen
Yu-Min Yeh
Hsuan-Yi Huang
Yu-Lin Ting
Pei-An Fu
Tzu-Chien Lin
I-Ting Liu
Chia-Jui Yen
机构
[1] National Cheng Kung University Hospital,Department of Oncology
[2] College of Medicine,Institute of Clinical Medicine, College of Medicine
[3] National Cheng Kung University,Division of Colorectal Surgery, Department of Surgery
[4] National Cheng Kung University,undefined
[5] Chi Mei Medical Center,undefined
来源
Targeted Oncology | 2023年 / 18卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:611 / 623
页数:12
相关论文
共 50 条
  • [1] Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours
    Yen, Chih-Chieh
    Yeh, Yu-Min
    Huang, Hsuan-Yi
    Ting, Yu-Lin
    Fu, Pei-An
    Lin, Tzu-Chien
    Liu, I-Ting
    Yen, Chia-Jui
    TARGETED ONCOLOGY, 2023, 18 (04) : 611 - 623
  • [2] Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
    Hegde, Aparna
    Andreev-Drakhlin, Alexander Y.
    Roszik, Jason
    Huang, Le
    Liu, Shuang
    Hess, Kenneth
    Cabanillas, Maria
    Hu, Mimi, I
    Busaidy, Naifa L.
    Sherman, Steven, I
    Dadu, Ramona
    Grubbs, Elizabeth G.
    Ali, Siraj M.
    Lee, Jessica
    Elamin, Yasir Y.
    Simon, George R.
    Blumenschein, George R., Jr.
    Papadimitrakopoulou, Vassiliki A.
    Hong, David
    Meric-Bernstam, Funda
    Heymach, John
    Subbiah, Vivek
    ESMO OPEN, 2020, 5 (05)
  • [3] YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers
    Katayama, Yuki
    Yamada, Tadaaki
    Tanimura, Keiko
    Kawachi, Hayato
    Ishida, Masaki
    Matsui, Yohei
    Hirai, Soichi
    Nakamura, Ryota
    Morimoto, Kenji
    Furuya, Naoki
    Arai, Sachiko
    Goto, Yasuhiro
    Sakata, Yoshihiko
    Nishino, Kazumi
    Tsuchiya, Michiko
    Tamiya, Akihiro
    Saito, Go
    Muto, Satoshi
    Takeda, Takayuki
    Date, Koji
    Fujisaka, Yasuhito
    Watanabe, Satoshi
    Fujimoto, Daichi
    Uehara, Hisanori
    Horinaka, Mano
    Sakai, Toshiyuki
    Yano, Seiji
    Tokuda, Shinsaku
    Takayama, Koichi
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1127 - 1141
  • [4] Responsiveness to immune checkpoint inhibitors in RET dependent cancers
    Hegde, Aparna
    Huang, Le
    Liu, Shuang
    Hess, Kenneth
    Cabanillas, Maria
    Hu, Mimi
    Busaidy, Naifa
    Sherman, Steven
    Simon, George
    Blumenschein, George
    Papadimitrakopoulou, Vassiliki A.
    Hong, David S.
    Meric-Bernstam, Funda
    Heymach, John
    Subbiah, Vivek
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma
    Zhao Gao
    Shikai Wu
    Yinmo Yang
    Mingxia Sun
    Xiaodong Tian
    Xuan Jin
    Investigational New Drugs, 2023, 41 : 719 - 726
  • [6] Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma
    Gao, Zhao
    Wu, Shikai
    Yang, Yinmo
    Sun, Mingxia
    Tian, Xiaodong
    Jin, Xuan
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (05) : 719 - 726
  • [7] Clinical characteristics and prognosis of pancreatitis associated with immune checkpoint inhibitors
    Zhang, Junzi
    Jiang, Xianzhuo
    Liu, Ning
    Qi, Zhaoxue
    Mi, Xuguang
    Fang, Yanqiu
    Zhang, Wenqi
    Yang, Zhen
    Ou, Wenjie
    Lin, Xiuying
    Hou, Junjie
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (01): : 333 - 339
  • [8] Responses to immune checkpoint inhibitors in nonagenarians
    Johnpulle, Romany A. N.
    Conry, Robert M.
    Sosman, Jeffrey A.
    Puzanov, Igor
    Johnson, Douglas B.
    ONCOIMMUNOLOGY, 2016, 5 (11):
  • [9] Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors
    Miller, Ethan D.
    Abu-Sbeih, Hamzah
    Styskel, Brett
    Gonzalez, Graciela M. Nogueras
    Blechacz, Boris
    Naing, Aung
    Chalasani, Naga
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02): : 251 - 261
  • [10] A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors
    Liu, Jun-Chen
    Yu, Hong -Jing
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 : 29 - 36